2021. Hepatic Adverse Effects and Genetic Polymorphisms of NAT2 and CYP2C9. Precision Medicine Communications. 1, 1 (Dec. 2021), 05–07. DOI:https://doi.org/10.55627/pmc.001.01.0072.